Jeffrey A Zonder (Jeffrey Zonder)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Patient Reported

Multiple Myeloma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

British journal of haematology

JCO oncology practice

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman, Attaya Suvannasankha, Jeffrey A Zonder, Mansi R Shah, Suzanne Lentzch, Rachid C Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca W Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquin Martinez Lopez, Kaniel Cassady, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, George D Yancopoulos, L Andres Sirulnik, Karen Rodriguez Lorenc, Glenn S Kroog, Yariv Houvras, Madhav V Dhodapkar
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman, Attaya Suvannasankha, Jeffrey A Zonder, Mansi R Shah, Suzanne Lentzch, Rachid C Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca W Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquin Martinez Lopez, Kaniel Cassady, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, George D Yancopoulos, L Andres Sirulnik, Karen Rodriguez Lorenc, Glenn S Kroog, Yariv Houvras, Madhav V Dhodapkar
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman, Attaya Suvannasankha, Jeffrey A Zonder, Mansi R Shah, Suzanne Lentzch, Rachid C Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca W Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquin Martinez Lopez, Kaniel Cassady, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, George D Yancopoulos, L Andres Sirulnik, Karen Rodriguez Lorenc, Glenn S Kroog, Yariv Houvras, Madhav V Dhodapkar
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman, Attaya Suvannasankha, Jeffrey A Zonder, Mansi R Shah, Suzanne Lentzch, Rachid C Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca W Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquin Martinez Lopez, Kaniel Cassady, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, George D Yancopoulos, L Andres Sirulnik, Karen Rodriguez Lorenc, Glenn S Kroog, Yariv Houvras, Madhav V Dhodapkar
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (22) (2024)
Benjamin A Derman, Ajai Chari, Jeffrey A Zonder, Ajay Major, Andrew T Stefka, Ken Jiang, Theodore Karrison, Jagoda Jasielec, Andrzej J Jakubowiak
A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma. European journal of haematology (2023)
Yang Yu, Niquelle Brown Wadé, Amie E Hwang, Ajay K Nooka, Mark A Fiala, Ann Mohrbacher, Edward S Peters, Karen Pawlish, Cathryn Bock, David Van Den Berg, Kristin A Rand, Daniel Stram, David V Conti, Daniel Auclair, Graham A Colditz, Jayesh Mehta, Christopher A Haiman, Howard Terebelo, Nalini Janakiraman, Seema Singhal, Brian Chiu, Ravi Vij, Leon Bernal-Mizrachi, Jeffrey A Zonder, Carol A Huff, Sagar Lonial, Robert Z Orlowski, Wendy Cozen, Sikandar Ailawadhi
Variability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United States. JCO oncology practice 16 (10) (2020)
Andrzej J Jakubowiak, Jagoda K Jasielec, Cara A Rosenbaum, Craig E Cole, Ajai Chari, Joseph Mikhael, Jennifer Nam, Amanda McIver, Erica Severson, Leonor A Stephens, Kathryn Tinari, Shaun Rosebeck, Todd M Zimmerman, Tyler Hycner, Agata Turowski, Theodore Karrison, Jeffrey A Zonder
Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma. British journal of haematology 186 (4) (2019)
Jeffrey A Zonder
The difficult business of assessing new therapies for smouldering multiple myeloma. British journal of haematology 182 (4) (2018)
Jack Khouri, Andrew Kin, Bicky Thapa, Frederic J Reu, Naresh Bumma, Christy J Samaras, Hien D Liu, Mary A Karam, Janice Reed, Saveta Mathur, Beth M Faiman, Georgia Devries, Jeffrey A Zonder, Jason Valent
Daratumumab proves safe and highly effective in AL amyloidosis. British journal of haematology 185 (2) (2018)